Subsets of human type 2 macrophages show differential capacity to produce reactive oxygen species

Cellular Immunology

Volumn 284, Issue 1-2, 2013, Pages 1-8

  Kraaij, Marina D ^a   Koekkoek, Karin M ^a   Van der Kooij, Sandra W ^a   Gelderman, Kyra A ^a,b   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Catalase; DPI; Macrophage; ROS; T cell

Indexed keywords

CD40 ANTIGEN; COLONY STIMULATING FACTOR 1; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CAT; CATALASE; DIPHENYLENEIODONIUM; DPI; MACROPHAGE; MPH; NADPH OXIDASE; NOX2; ROS; T CELL;

FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; ONIUM COMPOUNDS; POLYMERASE CHAIN REACTION; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 84881219550     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.07.006     Document Type: Article

References (44)

1. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Frontiers in Bioscience 2008, 13:453-461.
2. Ambarus C.A., Krausz S., van E.M., Hamann J., Radstake T.R., Reedquist K.A., Tak P.P., Baeten D.L. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. Journal of Immunological Methods 2011, 375:196-206.
3. Bogdan C., Nathan C. Modulation of macrophage function by transforming growth-factor-beta, Interleukin-4, and Interleukin-10. Annals of the New York Academy of Sciences 1993, 685:713-739.
4. Kraaij M.D., van der Kooij S.W., Reinders M.E., Koekkoek K., Rabelink T.J., van Kooten C., Gelderman K.A. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Molecular Immunology 2011, 49:549-557.
5. Verreck F.A.W., de Boer T., Langenberg D.M.L., van der Zanden L., Ottenhoff T.H.M. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. Journal of Leukocyte Biology 2006, 79:285-293.
6. Raes G., De Baetselier P., Noel W., Beschin A., Brombacher F., Hassanzadeh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. Journal of Leukocyte Biology 2002, 71:597-602.
7. Van den Heuvel M.M., Tensen C.P., van As J.H., van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A., Sorg C., Hogger P., Beelen R.H.J. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. Journal of Leukocyte Biology 1999, 66:858-866.
8. Gustafsson C., Mjosberg J., Matussek A., Geffers R., Matthiesen L., Berg G., Sharma S., Buer J., Ernerudh J. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008, 3:e2078.
9. Mues B., Langer D., Zwadlo G., Sorg C. Phenotypic characterization of macrophages in human term placenta. Immunology 1989, 67:303-307.
10. Mantovani A., Sica A., Allavena P., Garlanda C., Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Human Immunology 2009, 70:325-330.
11. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004, 25:677-686.
12. Ricardo S.D., van Goor H., Eddy A.A. Macrophage diversity in renal injury and repair. Journal of Clinical Investigation 2008, 118:3522-3530.
13. Verreck F.A.W., de Boer T., Langenberg D.M.L., Hoeve M.A., Kramer M., Vaisberg E., Kastelein R., Kolk A., de Waal-Malefyt R., Ottenhoff T.H.M. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4560-4565.
14. Xu W., Roos A., Schlagwein N., Woltman A.M., Daha M.R., van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 2006, 107:4930-4937.
15. Kraaij M.D., Savage N.D., van der Kooij S.W., Koekkoek K., Wang J., van den Berg J.M., Ottenhoff T.H., Kuijpers T.W., Holmdahl R., van Kooten C., Gelderman K.A. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:17686-17691.
16. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of Immunology 2006, 177:7303-7311.
17. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunology 2010, 11:889-896.
18. Abramson S.L., Gallin J.I. Il-4 Inhibits superoxide production by human mononuclear phagocytes. Journal of Immunology 1990, 144:625-630.
19. Segal B.H., Veys P., Malech H., Cowan M.J. Chronic granulomatous disease: lessons from a rare disorder. Biology of Blood and Marrow Transplantation 2011, 17:S123-S131.
20. Gelderman K.A., Hultqvist M., Pizzolla A., Zhao M., Nandakumar K.S., Mattsson R., Holmdahl R. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. The Journal of Clinical Investigation 2007, 117:3020-3028.
21. Hultqvist M., Olofsson P., Holmberg J., Backstrom B.T., Tordsson J., Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:12646-12651.
22. Xu W., Schlagwein N., Roos A., van den Berg T.K., Daha M.R., van Kooten C. Human peritoneal macrophage show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. European Journal of Immunology 2007, 37:1594-1599.
23. Woltman A.M., van der Kooij S.W., de Fijter J.W., van Kooten C. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA(+) and CD45RO(+) T-cell populations. American Journal of Transplantation 2006, 6:2580-2591.
24. O'Donnell B.V., Tew D.G., Jones O.T., England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. The Biochemical Journal 1993, 290(Pt 1):41-49.
25. Stone J.R., Yang S. Hydrogen peroxide: a signaling messenger. Antioxidants & Redox Signaling 2006, 8:243-270.
26. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunology 2002, 3:1129-1134.
27. Balce D.R., Li B., Allan E.R., Rybicka J.M., Krohn R.M., Yates R.M. Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms. Blood 2011, 118:4199-4208.
28. Zhou Y.L., Lin G.F., Murtaugh M.P. Interleukin-4 suppresses the expression of macrophage nadph oxidase heavy-chain subunit (Gp91-Phox). Biochimica et Biophysica Acta-Molecular Cell Research 1995, 1265:40-48.
29. Wong H.L., Lotze M.T., Wahl L.M., Wahl S.M. Administration of recombinant Il-4 to humans regulates gene-expression, phenotype, and function in circulating monocytes. Journal of Immunology 1992, 148:2118-2125.
30. Khan N., Rahim S.S., Boddupalli C.S., Ghousunnissa S., Padma S., Pathak N., Thiagarajan D., Hasnain S.E., Mukhopadhyay S. Hydrogen peroxide inhibits IL-12 p40 induction in macrophages by inhibiting c-rel translocation to the nucleus through activation of calmodulin protein. Blood 2006, 107:1513-1520.
31. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007, 87:245-313.
32. Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. Journal of Biological Chemistry 1997, 272:15642-15649.
33. Kim J.H., Park S.H., Park S.G., Choi J.S., Xia Y., Sung J.H. The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells. Stem Cells and Development 2011, 20:1753-1761.
34. Rusyn I., Yamashina S., Segal B.H., Schoonhoven R., Holland S.M., Cattley R.C., Swenberg J.A., Thurman R.G. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Research 2000, 60:4798-4803.
35. Maemura K., Zheng Q.Z., Wada T., Ozaki M., Takao S., Aikou T., Bulkley G.B., Klein A.S., Sun Z.L. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunology and Cell Biology 2005, 83:336-343.
36. Matsue H., Edelbaum D., Shalhevet D., Mizumoto N., Yang C.D., Mummert M.E., Oeda J., Masayasu H., Takashima A. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. Journal of Immunology 2003, 171:3010-3018.
37. Moon E.Y., Noh Y.W., Han Y.H., Kim S.U., Kim J.M., Yu D.Y., Lim J.S. T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunology Letters 2006, 102:184-190.
38. Sklavos M.M., Tse H.M., Piganelli J.D. Redox modulation inhibits CD8 T cell effector function. Free Radical Biology and Medicine 2008, 45:1477-1486.
39. Abdi K. IL-12: the role of p40 versus p75. Scandinavian Journal of Immunology 2002, 56:1-11.
40. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy - review of a new approach. Pharmacological Reviews 2003, 55:241-269.
41. Donini M., Marongiu L., Fontana E., Dusi S. Prostate carcinoma cells LNCaP and glucan cooperate in induction of cytokine synthesis by dendritic cells: effect on natural killer cells and CD4(+) lymphocytes activation. Prostate 2012, 72:566-576.
42. Deng J., Wang X., Qian F., Vogel S., Xiao L., Ranjan R., Park H., Karpurapu M., Ye R.D., Park G.Y., Christman J.W. Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression. Journal of Immunology 2012, 188:5734-5740.
43. Warris A., Netea M.G., Wang J.E., Gaustad P., Kullberg B.J., Verweij P.E., Abrahamsen T.G. Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scandinavian Journal of Infectious Diseases 2003, 35:482-487.
44. George-Chandy A., Nordstrom I., Nygren E., Jonsson I.M., Postigo J., Collins L.V., Eriksson K. Th17 development and autoimmune arthritis in the absence of reactive oxygen species. European Journal of Immunology 2008, 38:1118-1126.